iBio to Report Fiscal 2023 Second Quarter Financial Results and Provide Corporate Update on Monday, February 14, 2023
BRYAN, Texas, Feb. 07, 2023 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming Manufacturing System®, announced today that it will report its fiscal 2023 second quarter…